Endurant Capital Management LP Aziyo Biologics, Inc. Transaction History

Endurant Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.48 - $8.94 $416,249 - $1.07 Million	119,612 Added 10.49%	1,259,544 $5.35 Million
Q3 2022 Nov 14, 2022	BUY	$5.72 - $7.76 $38,604 - $52,372	6,749 Added 0.6%	1,139,932 $8.21 Million
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.41 $136,298 - $175,646	23,704 Added 2.14%	1,133,183 $8.01 Million
Q1 2022 May 16, 2022	BUY	$4.31 - $7.58 $145,846 - $256,499	33,839 Added 3.15%	1,109,479 $6.6 Million
Q4 2021 Feb 14, 2022	BUY	$4.1 - $6.82 $504,422 - $839,064	123,030 Added 12.92%	1,075,640 $6.78 Million
Q3 2021 Nov 15, 2021	BUY	$6.75 - $9.52 $536,294 - $756,373	79,451 Added 9.1%	952,610 $6.63 Million
Q2 2021 Aug 16, 2021	BUY	$9.51 - $13.97 $2.75 Million - $4.05 Million	289,559 Added 49.62%	873,159 $8.39 Million
Q1 2021 May 17, 2021	BUY	$13.08 - $16.41 $2.29 Million - $2.88 Million	175,387 Added 42.96%	583,600 $8.07 Million
Q4 2020 Feb 16, 2021	BUY	$10.77 - $14.82 $4.4 Million - $6.05 Million	408,213 New	408,213 $5.56 Million

9.06M

893K

Ticker AZYO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,308,720
Market Cap $13.5M
Description
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.